ICAM1 and cholangiocarcinoma: Based on this discovered CCA therapeutic target, two ICAM1 ADCs were designed and constructed with different chemical linkers and payloads, and then their anti-tumor efficacies were evaluated on CCA by in vitro and in vivo experiments.